High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study

OBJECTIVE: Pharmacological treatment of non-alcoholic fatty liver disease (NAFLD) is still evolving. Probiotics could be a promising treatment option, but their effectiveness needs to be established. The present study aimed to evaluate the efficacy of a high potency multistrain probiotic in adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Duseja, Ajay, Acharya, Subrat K, Mehta, Manu, Chhabra, Shruti, Rana, Satyavati, Das, Ashim, Dattagupta, Siddhartha, Dhiman, Radha K, Chawla, Yogesh K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688701/
https://www.ncbi.nlm.nih.gov/pubmed/31423319
http://dx.doi.org/10.1136/bmjgast-2019-000315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688701/
https://www.ncbi.nlm.nih.gov/pubmed/31423319
http://dx.doi.org/10.1136/bmjgast-2019-000315

Ejemplares similares